The store will not work correctly when cookies are disabled.
N-(3-Trifluoromethylphenyl)pyrazine-2-carboxamide
ID: ALA510601
Cas Number: 81172-86-3
PubChem CID: 279879
Max Phase: Preclinical
Molecular Formula: C12H8F3N3O
Molecular Weight: 267.21
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1cccc(C(F)(F)F)c1)c1cnccn1
Standard InChI: InChI=1S/C12H8F3N3O/c13-12(14,15)8-2-1-3-9(6-8)18-11(19)10-7-16-4-5-17-10/h1-7H,(H,18,19)
Standard InChI Key: HSMQXQUUMWQMJA-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
-3.9264 -4.5291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9276 -5.3565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2128 -5.7694 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.4963 -5.3560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4992 -4.5255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2146 -4.1164 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7863 -4.1103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0703 -4.5201 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7894 -3.2853 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3573 -4.1049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3571 -4.5182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0695 -4.1037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0668 -3.2778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3458 -2.8682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3637 -3.2850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7853 -4.5138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4958 -4.9250 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.1970 -3.7989 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.3772 -5.2308 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4 5 1 0
8 10 1 0
2 3 1 0
10 11 2 0
5 6 2 0
11 12 1 0
6 1 1 0
12 13 2 0
1 2 2 0
13 14 1 0
5 7 1 0
14 15 2 0
15 10 1 0
3 4 2 0
12 16 1 0
7 8 1 0
16 17 1 0
16 18 1 0
7 9 2 0
16 19 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 267.21 | Molecular Weight (Monoisotopic): 267.0619 | AlogP: 2.75 | #Rotatable Bonds: 2 |
Polar Surface Area: 54.88 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.82 | CX Basic pKa: ┄ | CX LogP: 1.89 | CX LogD: 1.89 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.91 | Np Likeness Score: -2.27 |
References
1. Dolezal M, Dolezal M, Cmedlova P, Palek L, Vinsova J, Kunes J, Buchta V, Jampilek J, Kralova K.. (2008) Synthesis and antimycobacterial evaluation of substituted pyrazinecarboxamides., 43 (5): [PMID:17870211] [10.1016/j.ejmech.2007.07.013] |
2. PubChem BioAssay data set, |